Council for Trade-Related Aspects of Intellectual Property Rights - Technical cooperation activities : information from other intergovernmental organizations - United Nations Conference on Trade and Development (UNCTAD)

TECHNICAL COOPERATION ACTIVITIES: INFORMATION FROM
OTHER INTERGOVERNMENTAL ORGANIZATIONS

United Nations Conference on Trade and Development (UNCTAD)

At its meeting of 14-15 June 2023, the Council for TRIPS agreed to invite intergovernmental organization observers to the Council to update the information on their technical and financial cooperation programmes relating to the implementation of the TRIPS Agreement.

 

The present document reproduces the information which has been received from the United Nations Conference on Trade and Development (UNCTAD) by means of a communication dated 17 September 2023.

 

_______________

 

 

Introduction

1.  The UNCTAD Secretariat, in accordance with its mandate under Bridgetown Covenant (2021) and taking into account international and regional initiatives, such as those by the World Intellectual Property Organization (WIPO), World Health Organization (WHO), and the African Union, implements a work programme on advancing the development dimension of intellectual property (IP) rights as they relate to key economic sectors. The work programme is implemented by its Intellectual Property Unit, located within the Division on Investment and Enterprise.

2.  UNCTAD focuses on improving the effective participation of developing countries in international IP norm setting, upgrading national IP policies and advancing regional cooperation on IP rights. It also works on building coherence between IP, investment and trade policies to meet the Sustainable Development Goals, to address the changes brought by frontier technologies and to build productive capacity in vital sectors of developing countries' economies, with a priority on the bio-pharmaceutical and vaccine sectors. The work programme is partially funded by donor governments and institutions. Currently, the work programme targets technical assistance and capacity building in areas related to: (1) local pharmaceutical and vaccines production, including in the context of COVID-19 and anti‑microbial resistance (AMR); and (2) regional and national IP policies.